Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use ; volume:40 ; number:3 ; day:21 ; month:3 ; year:2024 ; pages:137 ; date:3.2024
Drugs & therapy perspectives ; 40, Heft 3 (21.3.2024), 137, 3.2024
- Creator
-
Nie, Tina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40267-024-01061-0
- URN
-
urn:nbn:de:101:1-2406241204409.266065493488
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nie, Tina
- SpringerLink (Online service)
Other Objects (12)
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Untersuchungen zur Adhärenz von Bacillus Calmette Guérin (BCG) an permanenten Blasentumorzellinien
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Untersuchungen zur Adhärenz von Bacillus Calmette Guérin (BCG) an permanenten Blasentumorzellinien
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Untersuchungen zur Adhärenz von Bacillus Calmette Guérin (BCG) an permanenten Blasentumorzellinien
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)